Journos News
Thursday, November 27, 2025
  • Login
  • Home
  • Breaking News
  • World News
  • Politics
  • Business
  • Conflict and Crisis
  • Sports
  • Technology
  • Entertainment
  • Health
No Result
View All Result
  • Home
  • Breaking News
  • World News
  • Politics
  • Business
  • Conflict and Crisis
  • Sports
  • Technology
  • Entertainment
  • Health
No Result
View All Result
Journos News
No Result
View All Result
Home Health Consumer Awareness

FDA Says Popular Cold Medicine Doesn’t Work – Here’s What to Use Instead

Major Cold Medicine Change: FDA Moves to Ban Ineffective Decongestant

The Daily Desk by The Daily Desk
November 16, 2025
in Consumer Awareness, Health, Health News, Pharmaceuticals, Public Health & Safety
0
FDA Declares Leading Decongestant Useless – What You Need to Know - Jonathan Poet/AP Photo

FDA to Ban Ineffective Decongestant – How It Affects Cold & Allergy Medicine - Jonathan Poet/AP Photo

FDA Declares Popular Decongestant Ineffective – What Now?

📢 Big Changes Coming to Cold & Cough Medicines
🏥 FDA Moves to Ban Phenylephrine in Pills & Syrups
💊 Consumers Must Turn to More Effective Alternatives

Popular Cold Medicine Ingredient Doesn’t Work, FDA Says

Big changes are coming to your local pharmacy’s cold and cough aisle. The Food and Drug Administration (FDA) has announced plans to phase out phenylephrine, a leading decongestant found in hundreds of over-the-counter (OTC) medications, including Sudafed PE, DayQuil, and NyQuil.

The reason? It doesn’t actually relieve nasal congestion.

Despite being a common ingredient in cold and allergy medications, experts have questioned phenylephrine’s effectiveness for years. Now, the FDA has formally proposed revoking its use in oral pills and liquid solutions, meaning drugmakers will soon have to remove or reformulate their products.

Why Is the FDA Taking Action Now?

The decision comes after federal health advisers voted unanimously last year that phenylephrine does not work when taken orally.

RELATED POSTS

‘The Microbiome Is a Bit Like a Forest’: Understanding Vaginal Bacteria and Women’s Health

Delhi’s Toxic Air Takes a Heavy Toll on Children’s Health

U.S. Medicare Cuts Prices on 15 High-Cost Drugs, Slashing Spending by 36%

Three-Year-Old Thrives After World-First Gene Therapy for Rare Hunter Syndrome

First Human Death from Rare H5N5 Bird Flu Reported in Washington

Global Experts Warn Ultra-Processed Foods Pose Rising Health Risks

Key Findings from FDA Experts:
Large, recent studies found phenylephrine was no better than a placebo at clearing nasal congestion.
Older studies from the 1960s and 1970s that initially supported the drug’s approval were found to be flawed and unreliable.
The $1.8 billion market for oral phenylephrine products could soon disappear.

Important Note: This decision only applies to oral phenylephrine (pills & syrups). Phenylephrine-based nasal sprays will remain available, as they are still considered effective.

What Are the Best Alternatives for Nasal Congestion?

With oral phenylephrine on the way out, what should you use instead?

Pseudoephedrine (Behind-the-Counter)

If you still prefer pills or syrups, you’ll need to ask for medications containing pseudoephedrine (the original decongestant in Sudafed).

Available behind the pharmacy counter (no prescription needed)
Found in Sudafed, Claritin-D, Allegra-D
More effective than phenylephrine

You must show a photo ID to purchase, due to laws preventing its misuse in methamphetamine production.

Nasal Sprays for Fast Relief

  • Saline sprays & rinses (e.g., Neti pots) – Quickly clear mucus buildup.
  • Nasal steroids (Flonase, Nasacort, Rhinocort) – Best for long-term congestion relief, but must be used daily for full effect.
  • Antihistamine sprays (Astepro) – Act faster than steroids for short-term relief.

Why Doesn’t Oral Phenylephrine Work?

According to University of Florida researchers, phenylephrine is quickly broken down in the stomach, making it ineffective before it even reaches the bloodstream.

Dr. Leslie Hendeles, a leading researcher on phenylephrine, explains:
“This is a good drug, but not when it’s swallowed. It gets inactivated in the gut, so it can’t get to the nose.”

Even at doses 400% higher than currently recommended, phenylephrine still failed to relieve congestion. Increasing the dose even more could lead to dangerously high blood pressure, which is why the FDA ruled out stronger doses as an option.

What Happens Next?

The process to remove oral phenylephrine from store shelves won’t happen overnight.

Next Steps in the FDA Process:
6-month public comment period – Consumers & companies can submit feedback.
FDA review & final decision – Could take over a year for drugmakers to reformulate or remove products.
Possible delays – Drug companies may request additional hearings, slowing the process further.

Drugmakers Pushing Back

The Consumer Healthcare Products Association, which represents drug manufacturers, wants to keep phenylephrine available, arguing that consumers should have the right to choose their medications.

However, researchers like Dr. Randy Hatton (who co-led the FDA petition) disagree:
“Choosing from something that doesn’t work isn’t really a choice.”

What Should Consumers Do Now?

Avoid OTC pills labeled ‘PE’ – They won’t help your congestion.
Ask for pseudoephedrine at the pharmacy counter – It’s still available and works better.
Use nasal sprays & saline rinses – These provide fast and effective relief.
Consult your doctor or pharmacist – They can recommend the best alternative for your symptoms.

With the FDA cracking down on ineffective medications, consumers will soon have better options to actually relieve congestion. Stay informed and choose medications that truly work!

Source

This article was rewritten by JournosNews.com based on verified reporting from trusted sources. The content has been independently reviewed, fact-checked, and edited for accuracy, neutrality, tone, and global readability in accordance with Google News and AdSense standards.

All opinions, quotes, or statements from contributors, experts, or sourced organizations do not necessarily reflect the views of JournosNews.com. JournosNews.com maintains full editorial independence from any external funders, sponsors, or organizations.

Stay informed with JournosNews.com — your trusted source for verified global reporting and in-depth analysis. Follow us on Google News, BlueSky, and X for real-time updates.

Tags: #AllergyRelief#ColdAndFlu#ColdMedicine#ColdRemedies#ConsumerHealth#DayQuil#Decongestant#DrugSafety#FDA#FDABan#FDAUpdate#Flonase#FluRemedies#FluSeason#HealthAlert#HealthCare#HealthNews#HealthTips#MedicalNews#MedicineUpdate#NasalCongestion#NasalSpray#OverTheCounter#PharmacyNews#Phenylephrine#Pseudoephedrine#SinusRelief#StayHealthy#Sudafed#WellnessTips
ShareTweetSend
The Daily Desk

The Daily Desk

The Daily Desk – Contributor, JournosNews.com, The Daily Desk is a freelance editor and contributor at JournosNews.com, covering politics, media, and the evolving dynamics of public discourse. With over a decade of experience in digital journalism, Jordan brings clarity, accuracy, and insight to every story.

Related Posts

Lactobacillus bacteria support vaginal and reproductive health - Prashanti Aswani/BBC
Health

‘The Microbiome Is a Bit Like a Forest’: Understanding Vaginal Bacteria and Women’s Health

November 27, 2025
Children wear masks outdoors in Delhi smog - AFP via Getty Images/BBC
Health

Delhi’s Toxic Air Takes a Heavy Toll on Children’s Health

November 27, 2025
Medicare lowers prices on high-cost prescription drugs in 2027 - REUTERS/Dado Ruvic/Illustration/File Photo
Health

U.S. Medicare Cuts Prices on 15 High-Cost Drugs, Slashing Spending by 36%

November 26, 2025
Young boy receives pioneering gene therapy at UK hospital - photo Chu family via BBC
Health

Three-Year-Old Thrives After World-First Gene Therapy for Rare Hunter Syndrome

November 24, 2025
First Human Death from Rare H5N5 Bird Flu Confirmed in Washington State - Miguel Martinez/Atlanta Journal-Constitution via AP, File
Health

First Human Death from Rare H5N5 Bird Flu Reported in Washington

November 22, 2025
Ultra-Processed Foods Linked to Chronic Diseases, Experts Warn - Getty Images/BBC
Health

Global Experts Warn Ultra-Processed Foods Pose Rising Health Risks

November 19, 2025
Unapproved Peptide Injections Surge as Celebrities Fuel Trend Amid FDA Safety Concerns - AP Photo/Javier Arciga
Health

Unapproved Peptide Injections Rise in Popularity Despite Regulatory and Safety Concerns

November 16, 2025
How to Store Groceries Safely and Extend Freshness - AP Photo/Cheyanne Mumphrey
Food Safety & Nutrition

Maximizing Grocery Freshness: Expert Tips for Safe Refrigeration

November 16, 2025
FDA Removes Longtime Warning from Menopause Hormone Drugs - AP Photo/Evan Vucci
Health

FDA Removes Long-Standing Safety Warning from Menopause Hormone Therapy Drugs

November 11, 2025
Load More
Next Post
Elephants Trumpet with Joy After 40km Journey to a Bigger Home - Jo Howell/Zoos Victoria via AP Photo

Nine Elephants Relocated to a Spacious Zoo – See Their Reaction!

Will Europe Build Its Own Army? Zelenskyy Says the Time Is Now - Matthias Shrader/AP Photo

Zelenskyy Calls for a European Army as U.S. Shifts Ukraine Policy

Will Russia Make Concessions? U.S. Officials Set to Begin Talks - AFP/Getty Images/Reuters/AP/CNN

Trump Officials to Meet Russian Leaders for Ukraine Peace Talks

JournosNews logo

Journos News delivers globally neutral, fact-based journalism that meets international media standards — clear, credible, and made for a connected world.

  • Categories
  • World News
  • Politics
  • Business & Economy
  • Conflict and Crisis
  • Sports
  • Technology
  • Entertainment
  • Science & Health
  • Lifestyle & Culture
  • Investigations & Watchdog
  • Resources
  • Submit a Story
  • Advertise with Us
  • Syndication & Partnerships
  • Site Map
  • Press & Media Kit
  • Editorial Team
  • Careers

Join thousands of readers receiving the latest updates, tips, and exclusive insights straight to their inbox. Never miss an important story again.

  • About Us
  • Accessibility Statement
  • Contact Us
  • Privacy Policy
  • Terms and Conditions

© JournosNews.com – Trusted source for breaking news, trending stories, and in-depth reports.
All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Breaking News
  • World News
  • Politics
  • Business
  • Conflict and Crisis
  • Sports
  • Technology
  • Entertainment
  • Health

© JournosNews.com – Trusted source for breaking news, trending stories, and in-depth reports.
All rights reserved.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.